Aflatoxin |
Heart, liver, and kidney toxicities |
In-vivo, male Sprague-Dawley rats |
Ethanolic onion extract (2 weeks, 5 mg/kg, p.o.) |
The protective role of these extracts may be due to their rich content of organosulfur compounds, which act as a precursor of GSH, which conjugates with aflatoxin-epoxide and results in the inhibition of epoxide binding to DNA |
(31) |
Clostridium botulinium
|
- |
In-vitro, Meat slurry |
onion oil (45 mg) was dissolved in miglyol to a final volume of 1.0 mL |
Onion oil reduces Toxin concentration produced in meat slurry systems by C. botulinum type A, B, and C |
(33) |
Clostridium difficile
|
Cell toxicity |
In-vitro, the Vero (African green monkey kidney) and HT-29 (human colon carcinoma) |
Fresh onion bulb extract |
Fresh onion bulb extracts reduced toxin production and activity significantly. |
(34) |
Nicotine |
Lung toxicity |
In-vivo, Sprague-Dawley adult male albino rats |
Onion extract (18 weeks, p.o.) |
Antioxidative and anti-lipid peroxidative mechanisms. |
(14) |
LPS |
Bone marrow toxicity |
In-vitro, MC3T3-E1 cells, |
Quercetin |
Restored LPS-suppressed bone mineralization and the mRNA and protein expression levels of osteoblast-specific genes such as Osterix (OSX), runt-related transcription factor 2 (Runx2), alkaline phosphatase (ALP) and osteocalcin (OCN) |
(21) |
LPS |
Cell toxicity |
In-vitro, BV-2 microglial cells, N27-A cells |
Methanol extract of onion |
Onion extract takes protective action against LPS and MPP+, and upregulates the antioxidant enzymes that could potentially be used in the therapy of neurodegenerative diseases |
(41) |
N. n. karachiensis toxin |
Hematotoxicity |
In-vitro , hen’s egg yolk mixture |
Ethanolic onion extract (0.1 to 0.6 mg/mL) |
Neutralize snake venom proteins due to the abundance of miscellaneous secondary metabolites. |
(35) |
N. n. karachiensis toxin
|
Heart, liver, kidney, and musculoskeletal toxicities |
In-vivo, male rabbits |
Ethanolic onion extract (100 mg/kg, sc) |
Secondary metabolites pose a hindrance in the binding of different snake venom enzymes to their potential targets. |
(36) |
N. n. karachiensis toxin |
Hematotoxicity |
In-vitro
|
Methanolic onion extract |
Secondary metabolites created disturbances in binding of 5í-nucleotidases to their receptor(s), therefore resulted in the recovery of different toxicities. |
(39) |
N. n. karachiensis toxin |
Hematotoxicity |
In-vitro, hen’s egg yolk mixture |
Ethanolic onion extract (0.1 to 0.6 mg/mL) |
Neutralize snake venom proteins due to the abundance of miscellaneous secondary metabolites. |
(37) |
Histamine |
Gastrointestinal toxicity |
In-vivo, rats |
allylsulfide, allyldisulfide and quercetin |
By inhibition of gastric secretion stimulation effect of histamine. |
(42) |